Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
about
The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disordersTranslocator protein 18 kDa (TSPO): molecular sensor of brain injury and repairCurrent status of PET imaging in Huntington's diseaseThe methodology of TSPO imaging with positron emission tomographyKynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyIron dysregulation in Huntington's diseaseGap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseasesGenetics and neuropathology of Huntington's diseaseMutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 miceLaquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's diseaseDoes neuroinflammation fan the flame in neurodegenerative diseases?Neuroimaging biomarkers of neurodegenerative diseases and dementiaThe yin and yang of microgliaMolecular imaging of movement disordersNeuroimmunology of Huntington's Disease: Revisiting Evidence from Human StudiesSystems biology of neurodegenerative diseasesIn vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's diseaseMolecular Imaging Markers to Track Huntington’s Disease PathologyBrain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s diseaseAnalysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.Neuroimaging in Huntington's disease.PET Neurochemical Imaging Modes.An alteration in the lateral geniculate nucleus of experimental glaucoma monkeys: in vivo positron emission tomography imaging of glial activation.Molecular Imaging of Huntington's Disease.Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.Visualising disease progression on multiple variables with vector plots and path plotsSeeking brain biomarkers for preventive therapy in Huntington disease.Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's diseaseTranslocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative DiseasesAngiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines.Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study.Microglial Activation in the Pathogenesis of Huntington's Disease.Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factorsThe role of microglia in human disease: therapeutic tool or target?Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's diseaseAutophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.
P2860
Q24641816-E5B74F45-057F-4E59-BEC2-F93B16FC7F94Q24644752-34B6C3D8-4FD6-42F1-A824-96FCBE5CF905Q26768644-8A9534BC-23A5-4369-BDAA-A9E90720DB54Q26778370-7D80DA04-9F82-4392-9448-4824AD6BED11Q26782867-76564303-88D6-41F3-A23F-2C7320068EDFQ26829932-8756D020-877C-46FE-965A-109B3BF73418Q27012316-26B08F78-CD2A-4DCF-A49C-D0097AB17205Q27023050-C200ACF7-BB45-41DB-85D4-931343D887BAQ27305680-B92DE0DA-6EF9-4BD7-A463-8603F3BB17A1Q27316866-18C77725-877C-41E1-BF48-372350EA956AQ27334472-6BB56EA0-F2FF-468E-A2E8-0ABF537F7629Q27498993-24FB508B-44C1-44CE-BA60-14B67A5F6B2DQ27691820-604EC560-B2F5-485B-8769-A05294EBC326Q27693871-5F619735-FCF4-45DE-9A14-F68D20DA9975Q28071336-8D42ADE7-8E4F-41B5-8B81-09D70A0AC485Q28072237-255F05D1-4C62-4639-A1BB-317E71772D21Q28080741-1D0A154C-E40E-4B88-9947-BA98E627D315Q28274003-F72DFF5B-CF5A-42C3-B0D2-4B5EF25D0C73Q29248766-52E3FC05-4ACE-4195-A64F-5B0870E4B14BQ30141537-70241A32-384E-44AF-8D5D-DB4E29CEFEF2Q30480013-75FD69A9-9EDB-41C2-801F-6BDD364C791DQ30834004-21512D91-BDDA-4C59-9402-C69C8A034AACQ31033080-6DC7F907-20A5-4A79-9353-377962DA0567Q31047724-75D1FE40-E4B1-4C54-B2FE-9A99DE9F751CQ31139686-7686F134-B9E3-4BBC-9DB1-E65976759EE3Q33291754-139C2865-9AB1-4324-933C-FFF3472F18D8Q33310422-A16B7849-9CF7-4B8F-AC4B-B26F57B994D4Q33454017-CB66C56B-5D88-45CC-84BE-382E492D4C19Q33606063-D9B878D0-2AD5-4EEA-BDF9-F1BAF6CBE3D2Q33614987-E6D5A599-6849-433E-9C2C-2455409D5080Q33624586-AA0AE8C5-B82C-4448-BD4E-D2A0D97C4EEFQ33720370-14D975BF-E258-4774-9678-5F81F790B3FCQ33729262-D9ACC0CB-B207-4FAC-B0AE-EC427302792EQ33809556-7D16D486-350D-4629-85A6-5159B692B726Q33959395-A77ECB68-3E33-4594-AE28-2D51BEB5DF16Q34038205-12A48CBF-3A2C-4A1A-A866-BDFAA7432D99Q34043950-D8D14719-B93B-42F5-B9C6-34EC221AB38CQ34287719-BD22DD5A-03B8-4A3A-9C10-391FC55534B0Q34581918-4780021A-D9F2-4F15-8520-0CDEDF2F734EQ34635445-8BB88A46-2F59-4546-8524-260AD02DBC3C
P2860
Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Microglial activation correlat ...... ase: a clinical and PET study.
@en
Microglial activation correlat ...... ase: a clinical and PET study.
@nl
type
label
Microglial activation correlat ...... ase: a clinical and PET study.
@en
Microglial activation correlat ...... ase: a clinical and PET study.
@nl
prefLabel
Microglial activation correlat ...... ase: a clinical and PET study.
@en
Microglial activation correlat ...... ase: a clinical and PET study.
@nl
P50
P1433
P1476
Microglial activation correlat ...... ease: a clinical and PET study
@en
P2093
P304
P356
10.1212/01.WNL.0000222734.56412.17
P407
P577
2006-06-01T00:00:00Z